Two papers involving a sample with a primary diagnosis of combat-related PTSD have demonstrated an inverse association between the severity of PTSD symptoms and the degree of methylation of the promoter region of the glucocorticoid receptor NR3C1 (Yehuda et al., 2013, 2014b). The gene discussed is NR3C1; the disease is post-traumatic stress disorder.